OPRL1 anticorps (AA 1-47) (FITC)

N° du produit ABIN725967

Cet anticorps anti-OPRL1 Polyclonal Lapin conjugué à FITC (ABIN725967) détecte spécifiquement OPRL1 dans WB, IF (cc) et IF (p). L’anticorps est réactif avec des échantillons de Souris.

Aperçu rapide pour OPRL1 anticorps (AA 1-47) (FITC) (ABIN725967)

Antigène: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OPRL1 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-OPRL1 anticorps (FITC)

Épitope: AA 1-47

Fonction: Nociceptin receptor Polyclonal Antibody, FITC Conjugated

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog,Cow,Pig,Horse,GuineaPig

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from mouse Nociceptin receptor

Isotype: IgG

Information d'application

Indications d'application: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur OPRL1

Antigène: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Autre désignation: Nociceptin receptor

Sujet:

Synonyms: KOR3, ORGC, ORL1, Oprl, XOR1, morc, KOR-3, LC132, MOR-C, Nociceptin receptor, K3 opiate receptor, Kappa-type 3 opioid receptor, Orphanin FQ receptor, Oprl1, Oor

Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

ID gène: 18389

UniProt: P35377